Pages that link to "Q38271936"
Jump to navigation
Jump to search
The following pages link to Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body (Q38271936):
Displaying 27 items.
- Heparin-hepatocyte growth factor complex with low plasma clearance and retained hepatocyte proliferating activity (Q29394896) (← links)
- Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective (Q33857362) (← links)
- Type I interferon receptor is a primary regulator of target-mediated drug disposition of interferon-beta in mice (Q34028124) (← links)
- Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus Monkeys (Q34293733) (← links)
- Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats (Q34363812) (← links)
- The role of pharmacokinetics in the development of biotechnologically derived agents (Q35572362) (← links)
- Scaling pharmacodynamics from in vitro and preclinical animal studies to humans (Q37055123) (← links)
- Transport of peptide and protein drugs across biological membranes (Q37946839) (← links)
- Pharmacokinetic Steady-States Highlight Interesting Target-Mediated Disposition Properties (Q38763479) (← links)
- Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution (Q40937831) (← links)
- Effect of brefeldin A and lysosomotropic reagents on intracellular trafficking of epidermal growth factor and transferrin in Madin-Darby canine kidney epithelial cells (Q40998325) (← links)
- Pharmacokinetics and pharmacodynamics of a recombinant human granulocyte colony-stimulating factor (Q41262276) (← links)
- Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification (Q41988329) (← links)
- A Tutorial on Target-Mediated Drug Disposition (TMDD) Models (Q42351659) (← links)
- Pharmacokinetic model of target-mediated disposition of thrombopoietin (Q42564517) (← links)
- General pharmacokinetic model for drugs exhibiting target-mediated drug disposition (Q43985366) (← links)
- Receptor-mediated pharmacokinetic/pharmacodynamic model of interferon-beta 1a in humans (Q44211849) (← links)
- Pharmacokinetic and pharmacodynamic modeling of romiplostim in animals (Q46358056) (← links)
- Pharmacokinetics and pharmacodynamics of PEGylated IFN-beta 1a following subcutaneous administration in monkeys (Q46382821) (← links)
- Numerical validation and properties of a rapid binding approximation of a target-mediated drug disposition pharmacokinetic model. (Q47822849) (← links)
- Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin (Q57677415) (← links)
- Comparison of the methods for determining cell-surface and intracellular receptors for epidermal growth factor in the rat liver (Q67936313) (← links)
- Localization of binding sites for epidermal growth factor (EGF) in rat kidney: evidence for the existence of low affinity EGF binding sites on the brush border membrane (Q67977682) (← links)
- Impact of receptor downregulation on clearance of two human EGFs with different receptor binding activity (Q71873394) (← links)
- Perturbation of epidermal growth factor clearance after radioiodination and its implications (Q73111134) (← links)
- Pharmacokinetics and pharmacodynamics of erythropoietin receptor in healthy volunteers (Q80177008) (← links)
- New Equilibrium Models of Drug-Receptor Interactions Derived from Target-Mediated Drug Disposition (Q88673210) (← links)